JP2024521098A5 - - Google Patents
Info
- Publication number
- JP2024521098A5 JP2024521098A5 JP2023571758A JP2023571758A JP2024521098A5 JP 2024521098 A5 JP2024521098 A5 JP 2024521098A5 JP 2023571758 A JP2023571758 A JP 2023571758A JP 2023571758 A JP2023571758 A JP 2023571758A JP 2024521098 A5 JP2024521098 A5 JP 2024521098A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163190964P | 2021-05-20 | 2021-05-20 | |
| US63/190,964 | 2021-05-20 | ||
| US202263341771P | 2022-05-13 | 2022-05-13 | |
| US63/341,771 | 2022-05-13 | ||
| PCT/US2022/030068 WO2022246084A1 (en) | 2021-05-20 | 2022-05-19 | Sars-cov-2 polypeptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024521098A JP2024521098A (ja) | 2024-05-28 |
| JPWO2022246084A5 JPWO2022246084A5 (https=) | 2025-05-28 |
| JP2024521098A5 true JP2024521098A5 (https=) | 2025-05-28 |
Family
ID=82321637
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023571758A Pending JP2024521098A (ja) | 2021-05-20 | 2022-05-19 | ＳＡＲＳ－ＣｏＶ－２ポリペプチド |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220370601A1 (https=) |
| EP (1) | EP4294440A1 (https=) |
| JP (1) | JP2024521098A (https=) |
| KR (1) | KR20240012394A (https=) |
| AU (1) | AU2022277697A1 (https=) |
| BR (1) | BR112023024034A2 (https=) |
| CA (1) | CA3212678A1 (https=) |
| IL (1) | IL308465A (https=) |
| MX (1) | MX2023013665A (https=) |
| WO (1) | WO2022246084A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240042070A1 (en) * | 2022-06-28 | 2024-02-08 | Transcode Therapeutics, Inc. | Nanoparticles and template directed rig-i agonist precursor compositions and uses thereof for cancer therapy |
| CN115947801B (zh) * | 2022-12-29 | 2026-02-06 | 中国疾病预防控制中心病毒病预防控制所 | 一种流感病毒通用和冠状病毒联合多肽及其疫苗的应用 |
| CN116143908A (zh) * | 2023-02-10 | 2023-05-23 | 武汉华美生物工程有限公司 | 一种针对VLPs类型抗原免疫产生高效价抗血清的方法 |
| WO2025231068A1 (en) * | 2024-04-30 | 2025-11-06 | The Regents Of The University Of Michigan | Compositions and methods for enhancing systemic and mucosal immune responses |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CR20220552A (es) * | 2020-04-02 | 2023-01-17 | Regeneron Pharma | Anticuerpos contra glicoproteína de espícula anti-sars-cov-2 y fragmentos de unión al antígeno |
| EP4132576A1 (en) * | 2020-04-09 | 2023-02-15 | Suzhou Abogen Biosciences Co., Ltd. | Nucleic acid vaccines for coronavirus |
| EP4138876A1 (en) * | 2020-04-23 | 2023-03-01 | ISA Pharmaceuticals B.V. | Immunization against sars-cov-related diseases |
| GB202011652D0 (en) * | 2020-07-28 | 2020-09-09 | Univ Oxford Innovation Ltd | Polypeptide panels and uses thereof |
| US11191827B1 (en) * | 2020-12-09 | 2021-12-07 | Tevogen Bio Inc. | COVID-19 peptide specific T-cells and methods of treating and preventing COVID-19 |
-
2022
- 2022-05-19 KR KR1020237039921A patent/KR20240012394A/ko active Pending
- 2022-05-19 MX MX2023013665A patent/MX2023013665A/es unknown
- 2022-05-19 JP JP2023571758A patent/JP2024521098A/ja active Pending
- 2022-05-19 US US17/748,715 patent/US20220370601A1/en active Pending
- 2022-05-19 WO PCT/US2022/030068 patent/WO2022246084A1/en not_active Ceased
- 2022-05-19 IL IL308465A patent/IL308465A/en unknown
- 2022-05-19 AU AU2022277697A patent/AU2022277697A1/en active Pending
- 2022-05-19 CA CA3212678A patent/CA3212678A1/en active Pending
- 2022-05-19 EP EP22735677.1A patent/EP4294440A1/en active Pending
- 2022-05-19 BR BR112023024034A patent/BR112023024034A2/pt unknown